Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-028131
Filing Date
2024-12-03
Accepted
2024-12-03 17:04:27
Documents
1
Period of Report
2024-11-29

Document Format Files

Seq Description Document Type Size
1 form4-12032024_101223.html 4  
1 form4-12032024_101223.xml 4 3370
  Complete submission text file 0001415889-24-028131.txt   4716
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Issuer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address
Wallace Craig S. (Reporting) CIK: 0002018705 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38661 | Film No.: 241523580